Genetic Engineering & Biotechnology News

AUG 2013

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/145822

Contents of this Issue

Navigation

Page 4 of 45

© 2013 PerkinElmer, Inc. 400274_11. All trademarks or registered trademarks are the property of PerkinElmer, Inc. and/or its subsidiaries. HERE'S WHERE TRANSLATIONAL BECOMES TRANSFORMATIVE Te risks in drug discovery are huge – and the price of late-stage failure is astronomical. Tat's why researchers trust our translational imaging solutions to give them reliable, calibrated in vivo data that reveals pathway characterization, therapeutic efcacies, and toxicology for a broad range of indications. Our instruments, reagents, and applications have helped in hundreds of drug discovery projects over the years. And our hard-earned expertise makes us a trusted provider of pre-clinical imaging solutions (with 4,500 peer-reviewed articles as proof). Best of all, more than 15 blockbuster drugs have progressed through clinical trials using our in vivo solutions Maybe yours is next? Visit Booth #703 at WMIC to learn more about our new imaging system. For laboratory use only. T is product is intended for animal research only and not for use in humans.

Articles in this issue

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - AUG 2013